Category: Diagnostics
Global Diagnostics
-
Coagulation Testing
... CAGR of 4.8% over the analysis period 2024-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More
-
CBCT / Cone Beam Imaging
... Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Standing Patient Position, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$968.6 ... Read More
-
Cell Signaling
... CAGR of 5.4% over the analysis period 2024-2030. Cell Signaling Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$4.5 Billion by the end of the ... Read More
-
Cardiovascular Ultrasound Systems
... at a CAGR of 5.1% over the analysis period 2024-2030. Stress Echocardiogram Test, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$1.0 Billion by the end ... Read More
-
Heavy Metal Testing
... at a CAGR of 4.7% over the analysis period 2024-2030. Arsenic Testing, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.1 Billion by the end of ... Read More
-
Influenza Diagnostics
... CAGR of 5.2% over the analysis period 2024-2030. RIDT Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.0 Billion by the end of the analysis ... Read More
-
Urinalysis
... 5.0% over the analysis period 2024-2030. Urinalysis Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth ... Read More
-
Veterinary Diagnostics
... CAGR of 7.0% over the analysis period 2024-2030. Veterinary Diagnostic Consumables, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
X-Ray Crystallography
... CAGR of 11.4% over the analysis period 2024-2030. Pharmaceutical End-Use, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$944.5 Million by the end of the analysis ... Read More
-
Antithrombin
... 5.3% over the analysis period 2024-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$847.5 Million by the end of the analysis period. Growth ... Read More
-
Breath Analyzers
... CAGR of 15.4% over the analysis period 2024-2030. Fuel Cells Technology, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
Dental Diagnostic Imaging Equipment
... 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Intraoral Imaging Systems, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$3.3 Billion by ... Read More
-
Veterinary CT Scanners
... at a CAGR of 5.3% over the analysis period 2024-2030. Stationary Multi Slice CT Scanners, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$175.7 Million by ... Read More
-
Rapid Medical Diagnostic Kits
... 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$10.7 ... Read More
-
Veterinary Ultrasound Scanners
... at a CAGR of 4.9% over the analysis period 2024-2030. Portable Ultrasound Scanners, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$327.4 Million by the end ... Read More
-
Flow Chemistry
... CAGR of 8.8% over the analysis period 2024-2030. CSTR, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the analysis period. ... Read More
-
Drug Abuse Testing
... at a CAGR of 5.3% over the analysis period 2024-2030. Laboratory Services, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$52.0 Billion by the end of ... Read More
-
Industrial Microbiology
... CAGR of 4.6% over the analysis period 2024-2030. Pharmaceuticals End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More
-
Inorganic Scintillators
... CAGR of 5.5% over the analysis period 2024-2030. Sodium Iodide (NaI) Scintillation Material, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$200.2 Million by the end ... Read More
-
Leukapheresis
... 7.0% over the analysis period 2024-2030. Leukapheresis Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$122.6 Million by the end of the analysis period. Growth ... Read More
-
Life Science Instrumentation
... at a CAGR of 4.6% over the analysis period 2024-2030. Spectroscopy Technology, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$24.4 Billion by the end of ... Read More
-
Plasma Fractionation
... CAGR of 5.1% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.8 Billion by the end of the analysis period. ... Read More
-
Pneumonia Testing
... CAGR of 6.2% over the analysis period 2024-2030. Immunodiagnostics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$339.9 Million by the end of the analysis period. ... Read More
Research Assistance
